Shao J. Lin
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Immune and clinicopathological features of molecularly defined prolactinoma subtypes.
Journal: Journal of neurosurgery
Published: July 10, 2025
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death.
Journal: Autophagy
Published: June 15, 2017
Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 11, 2017
Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review.
Journal: Metabolic brain disease
Published: August 05, 2016
Long-Term Clinical Outcomes of Invasive Giant Prolactinomas after a Mean Ten-Year Followup.
Journal: International journal of endocrinology
Published: July 10, 2016
Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline.
Journal: Oncotarget
Published: July 07, 2015
Heat Shock Protein 47 Promotes Glioma Angiogenesis.
Journal: Brain pathology (Zurich, Switzerland)
Published: September 29, 2014
MicroRNA expression profile of bromocriptine-resistant prolactinomas.
Journal: Molecular and cellular endocrinology
Published: April 15, 2014
CTL responses to HSP47 associated with the prolonged survival of patients with glioblastomas.
Journal: Neurology
Published: March 14, 2014
Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.
Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.
Journal: Journal of immunology research
Published: March 08, 2014
Last Updated: 09/26/2026